A Phase II, Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study of GSK1278863, a HIF-Prolyl Hydroxylase Inhibitor, to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair
Clinical Trial Grant
Administered By
Surgery, Cardiovascular and Thoracic Surgery
Awarded By
GlaxoSmithKline
Start Date
November 1, 2013
End Date
October 31, 2015
Administered By
Surgery, Cardiovascular and Thoracic Surgery
Awarded By
GlaxoSmithKline
Start Date
November 1, 2013
End Date
October 31, 2015